Search results for "COVID-19"


 
Results 61 - 70 of about 416 for "COVID-19".
Sort by: Relevance | Newest | Oldest

COVID-19 and primary care

This issue also covers personal protective equipment and retirement planning.
https://acpinternist.org/archives/2020/07/covid-19-and-primary-care.htm
1 Jul 2020

Thriving at the annual meeting in your early-career years

I.M. Ready is a new regular feature that will explore topics relevant to early-career internal medicine physicians, particularly those within five years of residency graduation.
https://acpinternist.org/archives/2023/04/thriving-at-the-annual-meeting-in-your-early-career-years.htm
1 Apr 2023

Fighting COVID-19 vaccine fallacies with facts

This issue addressed COVID-19 vaccination and integrating oral health into primary care.
https://acpinternist.org/archives/2021/11/fighting-covid-19-vaccine-fallacies-with-facts.htm
1 Nov 2021

Register now for ACP and Annals of Internal Medicine's COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19

During the May 24 virtual live event, a panel of experts will discuss challenges related to the care of patients who have lasting symptoms following acute SARS-CoV-2 infection.
https://acpinternist.org/weekly/archives/2022/05/17/3.htm
17 May 2022

Supporting grieving patients after a loss

There are ways to talk to patients after the death of a loved one, recognize tips for diagnosing and managing prolonged grief disorder, and access grief counselors for referral.
https://acpinternist.org/archives/2023/01/supporting-grieving-patients-after-a-loss.htm
1 Jan 2023

ACP supports National Physician Suicide Awareness Day on Sept. 17

In a collaborative effort with ACP and other medical organizations, the Council of Residency Directors in Emergency Medicine calls on individuals, residency programs, health care organizations, and national groups to help spread awareness about the issue of physician suicide.
https://acpinternist.org/weekly/archives/2022/09/13/5.htm
13 Sep 2022

Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find

A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://acpinternist.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022

Testing offers hope, no panacea for COVID-19 control

A Q&A offers expert advice on the latest information about testing for COVID-19 from Elisa I. Choi, MD, FACP, Governor for ACP's Massachusetts Chapter and a fellow of the Infectious Diseases Society of America.
https://acpinternist.org/archives/2020/06/testing-offers-hope-no-panacea-for-covid-19-control.htm
1 Jun 2020

10 tips for well-being amid COVID-19

The global pandemic has professional and personal consequences for physicians, so experts offer their advice on coping during COVID-19.
https://acpinternist.org/archives/2020/07/10-tips-for-well-being-amid-covid-19.htm
1 Jul 2020

IDSA offers guidance on managing drug interactions with nirmatrelvir/ritonavir

The Infectious Diseases Society of America (IDSA) listed six steps to help clinicians prescribe the COVID-19 medication while minimizing interaction risks. Other recent research looked at neuropsychiatric conditions after COVID-19 and hospital profits during the pandemic.
https://acpinternist.org/weekly/archives/2022/05/17/2.htm
17 May 2022

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next